N-(6-((1-(difluoromethyl)piperidin-4-ylidene)fluoromethyl)pyridin-2-yl)-2,4,6-trifluorobenzamide

ID: ALA4871295

Chembl Id: CHEMBL4871295

PubChem CID: 164620307

Max Phase: Preclinical

Molecular Formula: C19H15F6N3O

Molecular Weight: 415.34

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(Nc1cccc(C(F)=C2CCN(C(F)F)CC2)n1)c1c(F)cc(F)cc1F

Standard InChI:  InChI=1S/C19H15F6N3O/c20-11-8-12(21)16(13(22)9-11)18(29)27-15-3-1-2-14(26-15)17(23)10-4-6-28(7-5-10)19(24)25/h1-3,8-9,19H,4-7H2,(H,26,27,29)

Standard InChI Key:  MADAKGCKOJJCCO-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4871295

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 415.34

Molecular Weight (Monoisotopic): 415.1119

AlogP: 4.75

#Rotatable Bonds: 4

Polar Surface Area: 45.23

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.30

CX Basic pKa: ┄

CX LogP: 4.49

CX LogD: 4.49

Aromatic Rings: 2

Heavy Atoms: 29

QED Weighted: 0.58

Np Likeness Score: -1.40

References

1. Jin C, Yi C, Zhong W, Xue Y, Chen K, Deng K, Wang Z, Wang T..  (2021)  Design, synthesis and biological evaluation of pyridinylmethylenepiperidine derivatives as potent 5-HT_1F receptor agonists for migraine therapy.,  225  [PMID:34419891] [10.1016/j.ejmech.2021.113782]

Source

Source(1):

• Scientific Literature